Zhuhai Rundu Pharmaceutical (002923.SZ): Isosorbide Dinitrate Injection Obtains Drug Registration Certificate

16:47 23/07/2026

Runto Pharmaceuticals (002923.SZ) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Isosorbide Dinitrate Injection (specification 5ml: 5mg). This drug is used for symptomatic treatment in combination with standard therapy for unstable angina, long-term treatment of vasospastic angina (variant angina), acute myocardial infarction, and acute left heart failure (heart failure with reduced left ventricular function).

Zhuhai Rundu Pharmaceutical (002923.SZ) announced that the company has recently received the Drug Registration Certificate for Isosorbide Dinitrate Injection (5ml: 5mg) issued by the National Medical Products Administration. This drug is used for symptomatic treatment in combination with standard therapy for unstable angina, long-term treatment of vasospastic angina (variant angina), acute myocardial infarction, and acute left heart failure (heart failure with decreased left ventricular function).

Fuyao Glass Industry Group (03606) completed the issuance of 300 million yuan worth of medium-term notes.

Ningbo Joyson Electronic Corp. (00699) spent 3.8748 million Hong Kong dollars on July 23 to buy back 300,000 shares.

Chairman of Wuchan Zhongda Geron (002722.SZ) proposed to repurchase company shares in the amount of 30-60 million yuan.

Fuyao Glass Industry Group (03606) completed the issuance of 300 million yuan worth of medium-term notes.

Ningbo Joyson Electronic Corp. (00699) spent 3.8748 million Hong Kong dollars on July 23 to buy back 300,000 shares.

Chairman of Wuchan Zhongda Geron (002722.SZ) proposed to repurchase company shares in the amount of 30-60 million yuan.